AI assistant
STRATA Skin Sciences, Inc. — Director's Dealing 2018
May 31, 2018
35146_dirs_2018-05-31_b3dec8f7-72ac-4ccb-a5e2-4ea9e5685f95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2018-05-29
Reporting Person: Accelmed Growth Partners, L.P. (10% Owner)
Reporting Person: Accelmed Growth Partners (GP), L.P. (10% Owner)
Reporting Person: Accelmed Growth Partners (AGP) Ltd (10% Owner)
Reporting Person: Accelmed Growth Partners Management Ltd. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.001 par value per share | 12037037 | Direct |
| Common Stock, $0.001 par value per share | 12037037 | Indirect |
| Common Stock, $0.001 par value per share | 12037037 | Indirect |
| Common Stock, $0.001 par value per share | 12037037 | Indirect |
Footnotes
F1: These shares are held directly by Accelmed Growth Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Growth Partners (GP), L.P., the general partner of Accelmed Growth Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Growth Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Growth Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of its pecuniary interest in the shares.